Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4351–4400 of 76267
In connection with Hugues Meyrath’s appointment as President and Chief Executive Officer of Quantum Corporation (the “Company”), on June 12, 2025, Mr. Meyrath entered into an offer letter (the “Offer Letter”) with the Company providing for the following terms:
On June 18, 2025, the Company announced that in connection with the workforce reduction, the employment of Carol D. Karp, the Company’s Chief Regulatory Officer, and David A. Ford, the Company’s Chief People Officer, will terminate effective August 1, 2025.
On June 18, 2025, the Company announced that in connection with the workforce reduction, the employment of Carol D. Karp, the Company’s Chief Regulatory Officer, and David A. Ford, the Company’s Chief People Officer, will terminate effective August 1, 2025.
On June 18, 2025, Barbara Weber, M.D., communicated her decision to resign from the board of directors (the “Board”) of Revolution Medicines, Inc.
As previously disclosed by the Company, Ms. DeCarolis will be succeeded as President of Distribution Corporation by Michael D. Colpoys, effective July 1, 2025.
As previously disclosed by the Company, Ms. DeCarolis has determined to retire from employment with the Company on July 1, 2025 (the “Retirement Date”).
On June 12, 2025, the Board of Directors (the “Board”) of Columbus Circle Capital Corp I (the “Company”) appointed Daniel Nash as Chief Operating Officer of the Company.
the Board appointed (i) Paul W. Kopsky, Jr. as a Class III member of the Board
Jeremy Garber, the Company’s President, Treasurer and Secretary was appointed to serve as the Company’s interim Chief Financial Officer while the Company conducts a search process for a permanent successor effective on the Transition Date.
Robert B. Klein announced his intention to resign from his role as Chief Financial Officer of Postal Realty Trust, Inc. (the “Company”) in order to accept a position with a privately-held real estate company.
Resignation of Jay Goodman
On June 16, 2025, the Board of Directors (the Board) of Citigroup Inc. (Citigroup) elected Jonathan Moulds as a director of Citigroup and appointed him to the Board’s Risk Management Committee and Transformation Oversight Committee.
Danny L. Titus and Thomas A. Haidlen have retired as directors of Oak Valley Bancorp (the “ Company ”) and of its wholly owned subsidiary Oak Valley Community Bank effective June 17, 2025.
Thomas A. Haidlen have retired as directors of Oak Valley Bancorp (the “ Company ”) and of its wholly owned subsidiary Oak Valley Community Bank effective June 17, 2025.
appointed John S. Pucin, age 59, as a Director of the Company and the Bank.
the Company’s Board appointed Keith Johnson as Chief Financial Officer of the Company.
the Board of Directors (the “Board”) of Amaze Holdings, Inc. (the “Company) appointed Aaron Day as Chief Executive Officer and Chairman of the Board of the Company.
On June 17, 2025, the Board of the General Partner of the Partnership and Carrie Clark, Senior Vice President and Chief Commercial Officer of the General Partner, agreed that Ms. Clark would depart her current roles at the general partner effective June 17, 2025.
On June 17, 2025, the board of directors (the “ Board ”) of Avalo Therapeutics, Inc. (the “ Company ”) appointed Rita Jain, M.D. to the Board, effective immediately.
On June 16, 2025, the Board of Directors (the “Board”) of the Company appointed Robert Goodman as a member of the Board.
On June 12, 2025, Warren Andrew Thomson resigned from the board of directors (the “Board”) of Connexa Sports Technologies Inc. (the “Company”) and all committees thereof, effective immediately.
On June 18, 2025, upon the recommendation of the Nominating and Governance Committee of the Board of Directors (the “Board”) of MetroCity Bankshares, Inc. (the “Company”), the Board voted to appoint Mr. David Shim to serve as a member of the Boards of Directors (collectively, the “Boards”) of the Company and Metro City Bank, the wholly owned subsidiary of the Company (the “Bank”), effective immediately.
On June 17, 2025, the Board of Directors (the “ Board ”) of Nextracker Inc. (the “ Company ”) increased the number of directors serving on the Board from nine to eleven and appointed Monica Karuturi and Mark Menezes to serve as directors of the Company.
On June 17, 2025, the Board of Directors (the “ Board ”) of Nextracker Inc. (the “ Company ”) increased the number of directors serving on the Board from nine to eleven and appointed Monica Karuturi and Mark Menezes to serve as directors of the Company.
unanimously appointed Saeju Jeong to fill the newly created vacancy on the Board, effective June 16, 2025.
David Feinberg will cease serving as AEP’s executive vice president and general counsel, effective July 13, 2025.
On June 16, 2025, the Board of Directors (the "Board") of Whirlpool Corporation (the "Company") appointed Judith K. Buckner as a director of Whirlpool Corporation and a member of the Board's Corporate Governance and Nominating Committee and Human Resources Committee, effective immediately.
The Company is appointing Dirk Naylor as Executive Vice President and General Manager, Communications & Security Solutions.
On June 12, 2025, William C. Geary, II, Executive Vice President and General Manager, Communications & Security Solutions, notified WESCO International, Inc. (the “Company”) that he is resigning from the Company to accept another position.
Riccardo Perfetti, M.D., Ph.D., departed his role as Chief Medical Officer, effective as of June 15, 2025.
Effective as of June 15, 2025, the Board appointed Evan P. Bailey, the Company’s Senior Vice President, Clinical Development, to succeed Dr. Perfetti as Chief Medical Officer.
On June 13, 2025, Dr. Fairooz Kabbinavar and Cardiff Oncology, Inc. (the “Company”) agreed that he would be stepping down from his position as Chief Medical Officer.
On June 17, 2025, the Company announced that it has appointed Dr. Roger Sidhu as its new Chief Medical Officer and entered into an employment agreement with Dr. Sidhu on June 16, 2025 (the “Sidhu Employment Agreement”).
elected Christopher Turner, currently Chief Financial and Franchise Officer of the Company, as Chief Executive Officer of the Company, effective October 1, 2025
David Gibbs, who, in March 2025, informed the Board of Directors of his intention to retire in the next year after 37 years with the Company and a successful tenure as CEO.
Mr. Cheatham will assume a senior finance leadership role with the Company.
appointed Paul Joachimczyk to the role of Chief Financial Officer, effective June 30, 2025.
David Harvey, the Company’s Chief Commercial Officer, will depart from his position with the Company effective June 19, 2025, but will continue to act as a senior advisor to the Company through August 2025.
On June 17, 2025 (the “Effective Date”), Wheels Up Experience Inc. (the “Company” or “Wheels Up”) announced that Mark Briffa has been promoted to the newly created position of Chief Sales Officer of Wheels Up, effective as of the Effective Date.
On June 17, 2025, RE/MAX Holdings, Inc. (the “Company”) announced that W. Grady Ligon, the Company’s Chief Information Officer, will be leaving the Company to pursue other opportunities closer to his home.
Effective June 16, 2025, Bank First Corporation director Laura E. Kohler retired from the Board of Directors (the “Board”).
New directors Daniel C. McConeghy and Michael S. Stayer-Suprick were elected to the Board.
New directors Daniel C. McConeghy and Michael S. Stayer-Suprick were elected to the Board.
On June 17, 2025, the Board elected Judith Murrah, the Company’s current President, as Chief Executive Officer and as Chairperson and a member of the Board effective June 18, 2025.
On June 16, 2025, Dr. James A. Hayward informed Applied DNA Sciences, Inc. (the “Company”) of his intention to retire from the Company and that he will step down from his positions as Chief Executive Officer, member of the Company’s board of directors (the “Board”) and Chairman of the Board effective June 18, 2025.
Noah Hoppe, James Franque and Felicity Black-Roberts were appointed as directors of Playa
Bruce D. Wardinski, Ryan Hymel and Tracy M.J. Colden each ceased to be executive officers of the Company.
Bruce D. Wardinski, Ryan Hymel and Tracy M.J. Colden each ceased to be executive officers of the Company.
Bruce D. Wardinski, Ryan Hymel and Tracy M.J. Colden each ceased to be executive officers of the Company.
Noah Hoppe, James Franque and Felicity Black-Roberts were appointed as directors of Playa
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.